

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 7.94589021 |
| 2 | negative regulation of interleukin-10 production (GO:0032693) | 5.87889034 |
| 3 | peptide catabolic process (GO:0043171) | 5.78505603 |
| 4 | regulation of T cell tolerance induction (GO:0002664) | 5.62147115 |
| 5 | positive regulation of receptor biosynthetic process (GO:0010870) | 5.59557623 |
| 6 | cellular protein complex localization (GO:0034629) | 5.56813646 |
| 7 | T-helper 1 type immune response (GO:0042088) | 5.46829869 |
| 8 | oxygen transport (GO:0015671) | 5.42832884 |
| 9 | * positive regulation of antigen processing and presentation (GO:0002579) | 5.38687274 |
| 10 | positive regulation of pseudopodium assembly (GO:0031274) | 5.38184653 |
| 11 | leukocyte tethering or rolling (GO:0050901) | 5.37354962 |
| 12 | myeloid dendritic cell differentiation (GO:0043011) | 5.35512694 |
| 13 | positive regulation of type 2 immune response (GO:0002830) | 5.34360968 |
| 14 | regulation of chronic inflammatory response (GO:0002676) | 5.17815710 |
| 15 | regulation of lipoprotein particle clearance (GO:0010984) | 5.13213638 |
| 16 | positive regulation of tolerance induction (GO:0002645) | 5.10594872 |
| 17 | striated muscle atrophy (GO:0014891) | 5.05751034 |
| 18 | * regulation of antigen processing and presentation (GO:0002577) | 5.02319895 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.01207842 |
| 20 | regulation of cellular extravasation (GO:0002691) | 4.98719679 |
| 21 | NIK/NF-kappaB signaling (GO:0038061) | 4.94782814 |
| 22 | * regulation of T-helper 1 cell differentiation (GO:0045625) | 4.92905711 |
| 23 | muscle atrophy (GO:0014889) | 4.90640899 |
| 24 | skeletal muscle adaptation (GO:0043501) | 4.85084729 |
| 25 | regulation of pseudopodium assembly (GO:0031272) | 4.82978971 |
| 26 | regulation of activation of Janus kinase activity (GO:0010533) | 4.79306850 |
| 27 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.78713027 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.76103827 |
| 29 | synaptic vesicle maturation (GO:0016188) | 4.76004300 |
| 30 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.72678683 |
| 31 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.72678683 |
| 32 | regulation of tolerance induction (GO:0002643) | 4.68339185 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.64603530 |
| 34 | trivalent inorganic anion homeostasis (GO:0072506) | 4.63762491 |
| 35 | phosphate ion homeostasis (GO:0055062) | 4.63762491 |
| 36 | kynurenine metabolic process (GO:0070189) | 4.59641409 |
| 37 | skeletal muscle tissue regeneration (GO:0043403) | 4.53883052 |
| 38 | cellular anion homeostasis (GO:0030002) | 4.50010869 |
| 39 | tryptophan catabolic process (GO:0006569) | 4.47396500 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 4.47396500 |
| 41 | indolalkylamine catabolic process (GO:0046218) | 4.47396500 |
| 42 | synapsis (GO:0007129) | 4.47210008 |
| 43 | myeloid dendritic cell activation (GO:0001773) | 4.35946778 |
| 44 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.31015549 |
| 45 | sympathetic nervous system development (GO:0048485) | 4.28880589 |
| 46 | negative regulation of muscle hypertrophy (GO:0014741) | 4.28283489 |
| 47 | heterotypic cell-cell adhesion (GO:0034113) | 4.27772515 |
| 48 | regulation of natural killer cell differentiation (GO:0032823) | 4.26948355 |
| 49 | amine biosynthetic process (GO:0009309) | 4.26473140 |
| 50 | cellular biogenic amine biosynthetic process (GO:0042401) | 4.26473140 |
| 51 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.23983126 |
| 52 | detection of bacterium (GO:0016045) | 4.19734676 |
| 53 | superoxide anion generation (GO:0042554) | 4.18682975 |
| 54 | collecting duct development (GO:0072044) | 4.17284094 |
| 55 | * positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.14112613 |
| 56 | hydrogen peroxide catabolic process (GO:0042744) | 4.14011471 |
| 57 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 4.09454848 |
| 58 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.08814962 |
| 59 | response to gravity (GO:0009629) | 4.07528088 |
| 60 | single strand break repair (GO:0000012) | 4.05395526 |
| 61 | regulation of bile acid biosynthetic process (GO:0070857) | 4.01332904 |
| 62 | cellular response to ATP (GO:0071318) | 4.00800125 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 3.91682114 |
| 64 | renal absorption (GO:0070293) | 3.90520464 |
| 65 | cellular response to type I interferon (GO:0071357) | 3.90303058 |
| 66 | type I interferon signaling pathway (GO:0060337) | 3.90303058 |
| 67 | ovulation from ovarian follicle (GO:0001542) | 3.89646244 |
| 68 | response to type I interferon (GO:0034340) | 3.89329600 |
| 69 | regulation of memory T cell differentiation (GO:0043380) | 3.87366062 |
| 70 | positive regulation of urine volume (GO:0035810) | 3.83675818 |
| 71 | detection of other organism (GO:0098543) | 3.80946217 |
| 72 | angiotensin maturation (GO:0002003) | 3.78835287 |
| 73 | catecholamine biosynthetic process (GO:0042423) | 3.75263774 |
| 74 | catechol-containing compound biosynthetic process (GO:0009713) | 3.75263774 |
| 75 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.74645878 |
| 76 | * positive regulation of granulocyte chemotaxis (GO:0071624) | 3.74645406 |
| 77 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 3.73190002 |
| 78 | regulation of interleukin-10 production (GO:0032653) | 3.70024473 |
| 79 | complement activation, classical pathway (GO:0006958) | 3.67472961 |
| 80 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.66993989 |
| 81 | * dendritic cell chemotaxis (GO:0002407) | 3.65335387 |
| 82 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.65133288 |
| 83 | nitric oxide biosynthetic process (GO:0006809) | 3.62728649 |
| 84 | glutathione biosynthetic process (GO:0006750) | 3.59063391 |
| 85 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.56221551 |
| 86 | cellular response to interferon-gamma (GO:0071346) | 3.53470954 |
| 87 | defense response to protozoan (GO:0042832) | 3.52395946 |
| 88 | * positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.52097031 |
| 89 | aorta morphogenesis (GO:0035909) | 3.50905922 |
| 90 | eosinophil migration (GO:0072677) | 3.50208826 |
| 91 | response to interferon-gamma (GO:0034341) | 3.49956554 |
| 92 | positive regulation of cholesterol efflux (GO:0010875) | 3.49498153 |
| 93 | * positive regulation of T-helper cell differentiation (GO:0045624) | 3.49487590 |
| 94 | * positive regulation of interleukin-12 production (GO:0032735) | 3.49436597 |
| 95 | * regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.48523599 |
| 96 | regulation of vitamin metabolic process (GO:0030656) | 3.48308266 |
| 97 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 3.47385437 |
| 98 | regulation of type 2 immune response (GO:0002828) | 3.46809237 |
| 99 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.46808291 |
| 100 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.46795482 |
| 101 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.46150352 |
| 102 | tryptophan metabolic process (GO:0006568) | 3.45997265 |
| 103 | * dendritic cell differentiation (GO:0097028) | 3.45800378 |
| 104 | * regulation of interleukin-12 production (GO:0032655) | 3.45475266 |
| 105 | sexual reproduction (GO:0019953) | 3.42207580 |
| 106 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.41139930 |
| 107 | neurotransmitter catabolic process (GO:0042135) | 3.40421474 |
| 108 | leukotriene biosynthetic process (GO:0019370) | 3.38806674 |
| 109 | negative regulation of interleukin-12 production (GO:0032695) | 3.37870276 |
| 110 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.36570867 |
| 111 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 3.32421353 |
| 112 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.28600030 |
| 113 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.26895544 |
| 114 | positive regulation of interleukin-10 production (GO:0032733) | 3.25090714 |
| 115 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.24286035 |
| 116 | negative regulation of cell killing (GO:0031342) | 3.24286035 |
| 117 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.22575178 |
| 118 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.21802945 |
| 119 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.21599848 |
| 120 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.21143143 |
| 121 | regulation of mononuclear cell migration (GO:0071675) | 3.21043932 |
| 122 | pyrimidine dimer repair (GO:0006290) | 3.20928248 |
| 123 | positive regulation of sterol transport (GO:0032373) | 3.20424939 |
| 124 | positive regulation of cholesterol transport (GO:0032376) | 3.20424939 |
| 125 | * regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.20385582 |
| 126 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.19670149 |
| 127 | biotin metabolic process (GO:0006768) | 3.19536736 |
| 128 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.19153769 |
| 129 | potassium ion homeostasis (GO:0055075) | 3.17747001 |
| 130 | lymphocyte chemotaxis (GO:0048247) | 3.15531699 |
| 131 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 3.15351649 |
| 132 | renal tubule development (GO:0061326) | 3.14163636 |
| 133 | vocalization behavior (GO:0071625) | 3.14075113 |
| 134 | * positive regulation of neutrophil chemotaxis (GO:0090023) | 3.11168856 |
| 135 | * positive regulation of neutrophil migration (GO:1902624) | 3.11168856 |
| 136 | regulation of integrin activation (GO:0033623) | 3.10951954 |
| 137 | positive regulation of T cell migration (GO:2000406) | 3.10548446 |
| 138 | protein complex localization (GO:0031503) | 3.08101416 |
| 139 | * regulation of T-helper cell differentiation (GO:0045622) | 3.07843039 |
| 140 | response to protozoan (GO:0001562) | 3.07477618 |
| 141 | T-helper cell differentiation (GO:0042093) | 3.07171126 |
| 142 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.07171126 |
| 143 | skin development (GO:0043588) | 3.06919460 |
| 144 | germinal center formation (GO:0002467) | 3.06648854 |
| 145 | regulation of receptor biosynthetic process (GO:0010869) | 3.05942115 |
| 146 | gas transport (GO:0015669) | 3.04030160 |
| 147 | response to muscle activity (GO:0014850) | 3.03123404 |
| 148 | lipoxygenase pathway (GO:0019372) | 3.02765129 |
| 149 | amine catabolic process (GO:0009310) | 3.02281469 |
| 150 | cellular biogenic amine catabolic process (GO:0042402) | 3.02281469 |
| 151 | * positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.01993393 |
| 152 | complement activation (GO:0006956) | 3.01907785 |
| 153 | hydrogen peroxide metabolic process (GO:0042743) | 3.01781991 |
| 154 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.00802311 |
| 155 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.00476033 |
| 156 | * regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.00278085 |
| 157 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.99589848 |
| 158 | fatty acid homeostasis (GO:0055089) | 2.99079905 |
| 159 | leukotriene metabolic process (GO:0006691) | 2.98628098 |
| 160 | regulation of T cell migration (GO:2000404) | 2.96964116 |
| 161 | axonal fasciculation (GO:0007413) | 2.96796160 |
| 162 | positive regulation of defense response to virus by host (GO:0002230) | 2.94772395 |
| 163 | B cell mediated immunity (GO:0019724) | 2.93004034 |
| 164 | interferon-gamma secretion (GO:0072643) | 2.92645157 |
| 165 | adhesion of symbiont to host cell (GO:0044650) | 2.92451498 |
| 166 | virion attachment to host cell (GO:0019062) | 2.92451498 |
| 167 | positive regulation of lymphocyte migration (GO:2000403) | 2.91998455 |
| 168 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.91994549 |
| 169 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.86794817 |
| 170 | * T cell costimulation (GO:0031295) | 2.86335702 |
| 171 | * regulation of T-helper 1 type immune response (GO:0002825) | 2.85134639 |
| 172 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.81808711 |
| 173 | * lymphocyte costimulation (GO:0031294) | 2.81633213 |
| 174 | regulation of regulatory T cell differentiation (GO:0045589) | 2.81193287 |
| 175 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.79587159 |
| 176 | neuron recognition (GO:0008038) | 2.77836551 |
| 177 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.76783925 |
| 178 | regulation of natural killer cell activation (GO:0032814) | 2.76709695 |
| 179 | regulation of urine volume (GO:0035809) | 2.76429506 |
| 180 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.76324467 |
| 181 | urea cycle (GO:0000050) | 2.76199850 |
| 182 | urea metabolic process (GO:0019627) | 2.76199850 |
| 183 | positive regulation of interleukin-17 production (GO:0032740) | 2.73414627 |
| 184 | regulation of RIG-I signaling pathway (GO:0039535) | 2.72269742 |
| 185 | * positive regulation of glycoprotein metabolic process (GO:1903020) | 2.72264569 |
| 186 | imidazole-containing compound metabolic process (GO:0052803) | 11.9372473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.89208933 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.63989517 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.94770084 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.14688202 |
| 5 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.46720770 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.42312636 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40366887 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.34872393 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32926147 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.31161923 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.29367452 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.26589223 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.24742233 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22891083 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.22807913 |
| 16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.16593642 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.09525154 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.09525154 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.08029217 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.07884306 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.99631732 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.97918374 |
| 23 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.96882982 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93741110 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.91667307 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.89817193 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.88032150 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.87746229 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.83670847 |
| 30 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.83118188 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.76510677 |
| 32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.75958302 |
| 33 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.73049282 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67233279 |
| 35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.66948796 |
| 36 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.65858439 |
| 37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.64143453 |
| 38 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.63450334 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62976462 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62423154 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62160627 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.61109215 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59387060 |
| 44 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.59241645 |
| 45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.57783860 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53600330 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52939979 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51799786 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51374596 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47634211 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46526949 |
| 52 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46452608 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.46441376 |
| 54 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.45894549 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45282998 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45116474 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.42700084 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42379016 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42003603 |
| 60 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.39598615 |
| 61 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.39373859 |
| 62 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38289987 |
| 63 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37181111 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.37162634 |
| 65 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.36295967 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34313170 |
| 67 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.31428003 |
| 68 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.30820079 |
| 69 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.30281080 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.29195452 |
| 71 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28999078 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.28724735 |
| 73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28605768 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27201940 |
| 75 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26355256 |
| 76 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25520289 |
| 77 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.24912704 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24157563 |
| 79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22655269 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22156802 |
| 81 | MYB_26560356_Chip-Seq_TH2_Human | 1.22151384 |
| 82 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21258406 |
| 83 | P300_19829295_ChIP-Seq_ESCs_Human | 1.21131581 |
| 84 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20056603 |
| 85 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19848791 |
| 86 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18159385 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18145221 |
| 88 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17686475 |
| 89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17686475 |
| 90 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.17675350 |
| 91 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.17620809 |
| 92 | MYC_22102868_ChIP-Seq_BL_Human | 1.16058418 |
| 93 | MYB_26560356_Chip-Seq_TH1_Human | 1.15331127 |
| 94 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15076926 |
| 95 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15020427 |
| 96 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14949885 |
| 97 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14179560 |
| 98 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13736755 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12671729 |
| 100 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12367412 |
| 101 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11803816 |
| 102 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11540812 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11533494 |
| 104 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10757322 |
| 105 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.10722711 |
| 106 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10532425 |
| 107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09911660 |
| 108 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09842084 |
| 109 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08939594 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08801820 |
| 111 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08654735 |
| 112 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08524055 |
| 113 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08332443 |
| 114 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.07995361 |
| 115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07739327 |
| 116 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07625369 |
| 117 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07590662 |
| 118 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06651944 |
| 119 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06196164 |
| 120 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.06182926 |
| 121 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.05920311 |
| 122 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05493226 |
| 123 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05284303 |
| 124 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04889410 |
| 125 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.04809769 |
| 126 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04609492 |
| 127 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03766632 |
| 128 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03019056 |
| 129 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02982736 |
| 130 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02624616 |
| 131 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02440750 |
| 132 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01562282 |
| 133 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01524584 |
| 134 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.01458242 |
| 135 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.01090600 |
| 136 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.00931962 |
| 137 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00922493 |
| 138 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00829523 |
| 139 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00539054 |
| 140 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00339016 |
| 141 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00111182 |
| 142 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00035149 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99904910 |
| 144 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99480212 |
| 145 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98486453 |
| 146 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.98186994 |
| 147 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97582148 |
| 148 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97512347 |
| 149 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97039120 |
| 150 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96964042 |
| 151 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96942252 |
| 152 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96786501 |
| 153 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96690335 |
| 154 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96486499 |
| 155 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96486499 |
| 156 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.96417934 |
| 157 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95732164 |
| 158 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.95045377 |
| 159 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94431254 |
| 160 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94022187 |
| 161 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93932696 |
| 162 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.93127713 |
| 163 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93049446 |
| 164 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92670359 |
| 165 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92237248 |
| 166 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91521438 |
| 167 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.91413246 |
| 168 | MAF_26560356_Chip-Seq_TH2_Human | 0.91255558 |
| 169 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.90677461 |
| 170 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90555448 |
| 171 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90357536 |
| 172 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90310321 |
| 173 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.90121267 |
| 174 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90030360 |
| 175 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.89837690 |
| 176 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.89378370 |
| 177 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.89034948 |
| 178 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.88806333 |
| 179 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88488885 |
| 180 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88365524 |
| 181 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88055938 |
| 182 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87748585 |
| 183 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87295370 |
| 184 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86426629 |
| 185 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86323085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 7.86674685 |
| 2 | MP0002876_abnormal_thyroid_physiology | 7.13525252 |
| 3 | MP0005645_abnormal_hypothalamus_physiol | 5.15225967 |
| 4 | MP0004510_myositis | 4.59155377 |
| 5 | MP0003303_peritoneal_inflammation | 4.32482767 |
| 6 | MP0001348_abnormal_lacrimal_gland | 3.86875607 |
| 7 | MP0003724_increased_susceptibility_to | 3.66029555 |
| 8 | MP0001346_abnormal_lacrimal_gland | 3.63225837 |
| 9 | * MP0000685_abnormal_immune_system | 3.50764936 |
| 10 | MP0001835_abnormal_antigen_presentation | 3.49018379 |
| 11 | MP0005647_abnormal_sex_gland | 3.44474999 |
| 12 | MP0002735_abnormal_chemical_nociception | 3.20272126 |
| 13 | MP0003436_decreased_susceptibility_to | 2.89577262 |
| 14 | MP0001873_stomach_inflammation | 2.87586866 |
| 15 | MP0005310_abnormal_salivary_gland | 2.82430344 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.75078637 |
| 17 | MP0002139_abnormal_hepatobiliary_system | 2.61266804 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 2.43030641 |
| 19 | MP0002160_abnormal_reproductive_system | 2.37712377 |
| 20 | MP0009840_abnormal_foam_cell | 2.28959903 |
| 21 | MP0005451_abnormal_body_composition | 2.21910181 |
| 22 | MP0003879_abnormal_hair_cell | 2.17643056 |
| 23 | MP0005671_abnormal_response_to | 2.08962148 |
| 24 | MP0004947_skin_inflammation | 2.00663696 |
| 25 | MP0003959_abnormal_lean_body | 1.91753883 |
| 26 | MP0005360_urolithiasis | 1.86471826 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.81294385 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 1.81190685 |
| 29 | MP0006082_CNS_inflammation | 1.77425234 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.75297144 |
| 31 | MP0005503_abnormal_tendon_morphology | 1.71236089 |
| 32 | MP0005166_decreased_susceptibility_to | 1.70138438 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.65229918 |
| 34 | MP0003075_altered_response_to | 1.53116710 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.52664520 |
| 36 | MP0003638_abnormal_response/metabolism_ | 1.46710373 |
| 37 | MP0003866_abnormal_defecation | 1.46505525 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.46231839 |
| 39 | MP0000003_abnormal_adipose_tissue | 1.36146894 |
| 40 | MP0002971_abnormal_brown_adipose | 1.34777957 |
| 41 | MP0001790_abnormal_immune_system | 1.31453965 |
| 42 | MP0005387_immune_system_phenotype | 1.31453965 |
| 43 | MP0008057_abnormal_DNA_replication | 1.29713784 |
| 44 | MP0002734_abnormal_mechanical_nocicepti | 1.27009909 |
| 45 | MP0003448_altered_tumor_morphology | 1.25553024 |
| 46 | MP0002733_abnormal_thermal_nociception | 1.24790634 |
| 47 | MP0000604_amyloidosis | 1.23290014 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.22311606 |
| 49 | MP0005389_reproductive_system_phenotype | 1.21463165 |
| 50 | MP0000343_altered_response_to | 1.20458405 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.19782762 |
| 52 | MP0000470_abnormal_stomach_morphology | 1.14828039 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 1.12792412 |
| 54 | MP0003868_abnormal_feces_composition | 1.12345022 |
| 55 | MP0001666_abnormal_nutrient_absorption | 1.11538435 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.09812406 |
| 57 | MP0002398_abnormal_bone_marrow | 1.09520441 |
| 58 | MP0002108_abnormal_muscle_morphology | 1.08877964 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.06803077 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.05757672 |
| 61 | MP0000858_altered_metastatic_potential | 1.05714975 |
| 62 | MP0001764_abnormal_homeostasis | 1.04565026 |
| 63 | MP0003195_calcinosis | 1.04511388 |
| 64 | MP0009764_decreased_sensitivity_to | 1.04285240 |
| 65 | MP0001853_heart_inflammation | 1.04191159 |
| 66 | MP0008004_abnormal_stomach_pH | 1.03667679 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.03018369 |
| 68 | MP0003045_fibrosis | 1.02350961 |
| 69 | MP0005025_abnormal_response_to | 1.02102619 |
| 70 | MP0005365_abnormal_bile_salt | 1.01811741 |
| 71 | MP0009115_abnormal_fat_cell | 0.99447936 |
| 72 | MP0009785_altered_susceptibility_to | 0.98688177 |
| 73 | MP0004858_abnormal_nervous_system | 0.98560839 |
| 74 | * MP0002429_abnormal_blood_cell | 0.98459757 |
| 75 | MP0006054_spinal_hemorrhage | 0.97640344 |
| 76 | MP0009278_abnormal_bone_marrow | 0.96996228 |
| 77 | MP0000490_abnormal_crypts_of | 0.96813648 |
| 78 | MP0001800_abnormal_humoral_immune | 0.96411376 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 0.94876630 |
| 80 | MP0009763_increased_sensitivity_to | 0.94801958 |
| 81 | MP0001485_abnormal_pinna_reflex | 0.94049326 |
| 82 | MP0009379_abnormal_foot_pigmentation | 0.92625083 |
| 83 | MP0008260_abnormal_autophagy | 0.91673848 |
| 84 | MP0002933_joint_inflammation | 0.91435777 |
| 85 | MP0008874_decreased_physiological_sensi | 0.86462732 |
| 86 | MP0005275_abnormal_skin_tensile | 0.86084558 |
| 87 | MP0003880_abnormal_central_pattern | 0.85165367 |
| 88 | MP0005334_abnormal_fat_pad | 0.84849864 |
| 89 | MP0002722_abnormal_immune_system | 0.84778264 |
| 90 | MP0004019_abnormal_vitamin_homeostasis | 0.83927502 |
| 91 | MP0003091_abnormal_cell_migration | 0.83658951 |
| 92 | MP0005381_digestive/alimentary_phenotyp | 0.83221284 |
| 93 | MP0003300_gastrointestinal_ulcer | 0.83109751 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.82414286 |
| 95 | MP0000538_abnormal_urinary_bladder | 0.81253622 |
| 96 | MP0005397_hematopoietic_system_phenotyp | 0.80421137 |
| 97 | MP0001545_abnormal_hematopoietic_system | 0.80421137 |
| 98 | MP0000689_abnormal_spleen_morphology | 0.80129638 |
| 99 | MP0002405_respiratory_system_inflammati | 0.80051661 |
| 100 | MP0000681_abnormal_thyroid_gland | 0.78342683 |
| 101 | MP0001881_abnormal_mammary_gland | 0.77718549 |
| 102 | MP0010386_abnormal_urinary_bladder | 0.77660907 |
| 103 | MP0002089_abnormal_postnatal_growth/wei | 0.77219904 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.77022834 |
| 105 | MP0000249_abnormal_blood_vessel | 0.76317427 |
| 106 | MP0001970_abnormal_pain_threshold | 0.76217200 |
| 107 | MP0005448_abnormal_energy_balance | 0.75204777 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.74467447 |
| 109 | MP0005000_abnormal_immune_tolerance | 0.74189418 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.72616277 |
| 111 | MP0000467_abnormal_esophagus_morphology | 0.72190079 |
| 112 | MP0001845_abnormal_inflammatory_respons | 0.71722475 |
| 113 | MP0005390_skeleton_phenotype | 0.71602525 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.71303140 |
| 115 | MP0002928_abnormal_bile_duct | 0.71176932 |
| 116 | MP0004270_analgesia | 0.70607707 |
| 117 | MP0001216_abnormal_epidermal_layer | 0.69782024 |
| 118 | MP0000678_abnormal_parathyroid_gland | 0.68849118 |
| 119 | MP0003828_pulmonary_edema | 0.68616552 |
| 120 | MP0001851_eye_inflammation | 0.67152070 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66758654 |
| 122 | MP0006276_abnormal_autonomic_nervous | 0.66157790 |
| 123 | MP0002166_altered_tumor_susceptibility | 0.64669522 |
| 124 | MP0000613_abnormal_salivary_gland | 0.64464328 |
| 125 | MP0004264_abnormal_extraembryonic_tissu | 0.63606749 |
| 126 | MP0005165_increased_susceptibility_to | 0.62104289 |
| 127 | MP0002796_impaired_skin_barrier | 0.61017248 |
| 128 | MP0005164_abnormal_response_to | 0.60789140 |
| 129 | MP0000383_abnormal_hair_follicle | 0.60149392 |
| 130 | MP0000609_abnormal_liver_physiology | 0.60116378 |
| 131 | MP0003329_amyloid_beta_deposits | 0.60104317 |
| 132 | MP0003690_abnormal_glial_cell | 0.60049095 |
| 133 | MP0000477_abnormal_intestine_morphology | 0.59746235 |
| 134 | MP0002970_abnormal_white_adipose | 0.59405118 |
| 135 | MP0002452_abnormal_antigen_presenting | 0.58997651 |
| 136 | MP0002723_abnormal_immune_serum | 0.58085723 |
| 137 | MP0002069_abnormal_eating/drinking_beha | 0.57299442 |
| 138 | MP0010155_abnormal_intestine_physiology | 0.55918028 |
| 139 | MP0004782_abnormal_surfactant_physiolog | 0.55893337 |
| 140 | MP0008872_abnormal_physiological_respon | 0.54087661 |
| 141 | MP0000579_abnormal_nail_morphology | 0.52419392 |
| 142 | MP0004134_abnormal_chest_morphology | 0.51445000 |
| 143 | MP0001819_abnormal_immune_cell | 0.50364491 |
| 144 | MP0002420_abnormal_adaptive_immunity | 0.49397769 |
| 145 | MP0002272_abnormal_nervous_system | 0.49220910 |
| 146 | MP0008469_abnormal_protein_level | 0.49085271 |
| 147 | MP0005464_abnormal_platelet_physiology | 0.47774602 |
| 148 | MP0001663_abnormal_digestive_system | 0.47506780 |
| 149 | MP0003890_abnormal_embryonic-extraembry | 0.47147694 |
| 150 | MP0002909_abnormal_adrenal_gland | 0.47054551 |
| 151 | MP0009643_abnormal_urine_homeostasis | 0.46915901 |
| 152 | MP0002693_abnormal_pancreas_physiology | 0.46126039 |
| 153 | MP0010678_abnormal_skin_adnexa | 0.46077830 |
| 154 | MP0002419_abnormal_innate_immunity | 0.44766901 |
| 155 | MP0002006_tumorigenesis | 0.44053071 |
| 156 | * MP0000716_abnormal_immune_system | 0.39631352 |
| 157 | MP0002896_abnormal_bone_mineralization | 0.39508939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.44709420 |
| 2 | Increased IgE level (HP:0003212) | 6.05595107 |
| 3 | Chronic mucocutaneous candidiasis (HP:0002728) | 6.01707196 |
| 4 | Recurrent cutaneous fungal infections (HP:0011370) | 6.01707196 |
| 5 | Malnutrition (HP:0004395) | 5.24015999 |
| 6 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 5.22258456 |
| 7 | Keratoconjunctivitis (HP:0001096) | 5.07760629 |
| 8 | Eczematoid dermatitis (HP:0000976) | 5.06066495 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 4.84199283 |
| 10 | Type I diabetes mellitus (HP:0100651) | 4.79714997 |
| 11 | Prolonged neonatal jaundice (HP:0006579) | 4.62424398 |
| 12 | Confusion (HP:0001289) | 4.55189927 |
| 13 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 4.08829373 |
| 14 | Asplenia (HP:0001746) | 3.97835687 |
| 15 | Vasculitis (HP:0002633) | 3.93112060 |
| 16 | Glomerulonephritis (HP:0000099) | 3.88900420 |
| 17 | Plantar hyperkeratosis (HP:0007556) | 3.82572403 |
| 18 | Recurrent skin infections (HP:0001581) | 3.79786965 |
| 19 | Optic neuritis (HP:0100653) | 3.76019730 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.76019730 |
| 21 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 3.72996778 |
| 22 | Palmoplantar hyperkeratosis (HP:0000972) | 3.69642523 |
| 23 | Complement deficiency (HP:0004431) | 3.65771836 |
| 24 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.63627450 |
| 25 | Abnormality of complement system (HP:0005339) | 3.61571283 |
| 26 | Abnormal pupillary function (HP:0007686) | 3.59383169 |
| 27 | Abnormality of macrophages (HP:0004311) | 3.57084265 |
| 28 | Hydroxyprolinuria (HP:0003080) | 3.55213431 |
| 29 | Abnormality of proline metabolism (HP:0010907) | 3.55213431 |
| 30 | Hemoptysis (HP:0002105) | 3.53121552 |
| 31 | Tongue fasciculations (HP:0001308) | 3.51991808 |
| 32 | Type 2 muscle fiber atrophy (HP:0003554) | 3.51290712 |
| 33 | Congenital malformation of the right heart (HP:0011723) | 3.51082943 |
| 34 | Double outlet right ventricle (HP:0001719) | 3.51082943 |
| 35 | Chronic diarrhea (HP:0002028) | 3.50801793 |
| 36 | Recurrent fungal infections (HP:0002841) | 3.50482696 |
| 37 | Right ventricular cardiomyopathy (HP:0011663) | 3.45982633 |
| 38 | Palmar hyperkeratosis (HP:0010765) | 3.41501991 |
| 39 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.37725011 |
| 40 | Upper limb muscle weakness (HP:0003484) | 3.37255552 |
| 41 | Emphysema (HP:0002097) | 3.33686512 |
| 42 | Poikilocytosis (HP:0004447) | 3.30794115 |
| 43 | Muscle fibrillation (HP:0010546) | 3.29726687 |
| 44 | Hypercortisolism (HP:0001578) | 3.24538050 |
| 45 | Abnormality of the gastric mucosa (HP:0004295) | 3.21757402 |
| 46 | Colitis (HP:0002583) | 3.20575361 |
| 47 | Reticulocytosis (HP:0001923) | 3.14803314 |
| 48 | Muscle fiber atrophy (HP:0100295) | 3.12940866 |
| 49 | Chronic otitis media (HP:0000389) | 3.11345137 |
| 50 | Onycholysis (HP:0001806) | 3.10263418 |
| 51 | Hypergammaglobulinemia (HP:0010702) | 3.09533425 |
| 52 | Abnormality of the nasal mucosa (HP:0000433) | 3.08555906 |
| 53 | Recurrent bronchitis (HP:0002837) | 3.07381734 |
| 54 | Pulmonary infiltrates (HP:0002113) | 3.06789625 |
| 55 | Fatigable weakness (HP:0003473) | 2.94759450 |
| 56 | Abnormality of the neuromuscular junction (HP:0003398) | 2.94759450 |
| 57 | Abnormality of glycolipid metabolism (HP:0010969) | 2.91196277 |
| 58 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.91196277 |
| 59 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.91196277 |
| 60 | Nephritis (HP:0000123) | 2.90908337 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.90572874 |
| 62 | Xerostomia (HP:0000217) | 2.89469880 |
| 63 | Recurrent viral infections (HP:0004429) | 2.85264228 |
| 64 | Keratoconjunctivitis sicca (HP:0001097) | 2.82146371 |
| 65 | IgA deficiency (HP:0002720) | 2.80978878 |
| 66 | Agammaglobulinemia (HP:0004432) | 2.79562565 |
| 67 | Gingivitis (HP:0000230) | 2.78124225 |
| 68 | Thin bony cortex (HP:0002753) | 2.76277116 |
| 69 | Recurrent bacterial skin infections (HP:0005406) | 2.75015873 |
| 70 | Supernumerary nipples (HP:0002558) | 2.74990982 |
| 71 | Chest pain (HP:0100749) | 2.74597183 |
| 72 | Respiratory distress (HP:0002098) | 2.74588807 |
| 73 | Tetraparesis (HP:0002273) | 2.74356211 |
| 74 | Milia (HP:0001056) | 2.72805983 |
| 75 | Nasal polyposis (HP:0100582) | 2.71361973 |
| 76 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.70233786 |
| 77 | Hypertensive crisis (HP:0100735) | 2.69923703 |
| 78 | Hyperglycemia (HP:0003074) | 2.67610131 |
| 79 | Dysostosis multiplex (HP:0000943) | 2.66232665 |
| 80 | Recurrent abscess formation (HP:0002722) | 2.61864899 |
| 81 | Truncus arteriosus (HP:0001660) | 2.61704964 |
| 82 | Autoimmune thrombocytopenia (HP:0001973) | 2.61160986 |
| 83 | Absent speech (HP:0001344) | 2.59581347 |
| 84 | Recurrent pneumonia (HP:0006532) | 2.56534927 |
| 85 | Restrictive lung disease (HP:0002091) | 2.55029032 |
| 86 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.51274187 |
| 87 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.50731841 |
| 88 | Loss of speech (HP:0002371) | 2.43449624 |
| 89 | Enlarged kidneys (HP:0000105) | 2.43310117 |
| 90 | Increased IgM level (HP:0003496) | 2.43036991 |
| 91 | Amyloidosis (HP:0011034) | 2.40658493 |
| 92 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40128559 |
| 93 | Obstructive lung disease (HP:0006536) | 2.40128559 |
| 94 | Premature loss of primary teeth (HP:0006323) | 2.39669991 |
| 95 | Weak cry (HP:0001612) | 2.36740410 |
| 96 | Encephalitis (HP:0002383) | 2.36712212 |
| 97 | Interstitial pulmonary disease (HP:0006530) | 2.36699030 |
| 98 | Urticaria (HP:0001025) | 2.36218430 |
| 99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.33997628 |
| 100 | Purpura (HP:0000979) | 2.33758644 |
| 101 | Gastrointestinal stroma tumor (HP:0100723) | 2.33722494 |
| 102 | Hypoplasia of the uterus (HP:0000013) | 2.33403855 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 2.33364602 |
| 104 | Amaurosis fugax (HP:0100576) | 2.33186041 |
| 105 | Abnormality of placental membranes (HP:0011409) | 2.32679662 |
| 106 | Amniotic constriction ring (HP:0009775) | 2.32679662 |
| 107 | Myositis (HP:0100614) | 2.31398394 |
| 108 | Joint swelling (HP:0001386) | 2.29428549 |
| 109 | Keratitis (HP:0000491) | 2.24358031 |
| 110 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.23776938 |
| 111 | Recurrent lower respiratory tract infections (HP:0002783) | 2.22772067 |
| 112 | Abnormality of the pleura (HP:0002103) | 2.21887799 |
| 113 | Fragile skin (HP:0001030) | 2.18079346 |
| 114 | Periodontitis (HP:0000704) | 2.17636178 |
| 115 | Lymphopenia (HP:0001888) | 2.15603195 |
| 116 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.14930624 |
| 117 | Villous atrophy (HP:0011473) | 2.14930624 |
| 118 | Autoimmune hemolytic anemia (HP:0001890) | 2.14645171 |
| 119 | Amelogenesis imperfecta (HP:0000705) | 2.14363617 |
| 120 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.14135467 |
| 121 | Arthralgia (HP:0002829) | 2.13953643 |
| 122 | Abnormality of T cell number (HP:0011839) | 2.11849028 |
| 123 | Annular pancreas (HP:0001734) | 2.11510777 |
| 124 | Hypophosphatemia (HP:0002148) | 2.10250650 |
| 125 | Cholelithiasis (HP:0001081) | 2.07141906 |
| 126 | Short 5th finger (HP:0009237) | 2.06811044 |
| 127 | Anorexia (HP:0002039) | 2.06067628 |
| 128 | Skin rash (HP:0000988) | 2.05822164 |
| 129 | Nausea (HP:0002018) | 2.05188940 |
| 130 | Hyperglycinuria (HP:0003108) | 2.04854375 |
| 131 | Hypoplasia of dental enamel (HP:0006297) | 2.04830748 |
| 132 | Orchitis (HP:0100796) | 2.04783413 |
| 133 | Hyperparathyroidism (HP:0000843) | 2.04004307 |
| 134 | Fibular aplasia (HP:0002990) | 2.03762979 |
| 135 | Abnormality of B cell number (HP:0010975) | 2.03189309 |
| 136 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.03089488 |
| 137 | Mucopolysacchariduria (HP:0008155) | 2.03089488 |
| 138 | Pustule (HP:0200039) | 2.02746643 |
| 139 | Increased cerebral lipofuscin (HP:0011813) | 2.01270021 |
| 140 | T lymphocytopenia (HP:0005403) | 2.01106864 |
| 141 | Bone pain (HP:0002653) | 2.00915098 |
| 142 | Vacuolated lymphocytes (HP:0001922) | 2.00363597 |
| 143 | Tubulointerstitial fibrosis (HP:0005576) | 1.99512618 |
| 144 | Pulmonary embolism (HP:0002204) | 1.98350810 |
| 145 | Panhypogammaglobulinemia (HP:0003139) | 1.98259151 |
| 146 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98180774 |
| 147 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98180774 |
| 148 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98180774 |
| 149 | Ventricular tachycardia (HP:0004756) | 1.97829278 |
| 150 | Vertebral compression fractures (HP:0002953) | 1.97352845 |
| 151 | Spontaneous hematomas (HP:0007420) | 1.95747854 |
| 152 | Fragile nails (HP:0001808) | 1.94951748 |
| 153 | Synostosis involving bones of the hand (HP:0004278) | 1.93590947 |
| 154 | Inflammation of the large intestine (HP:0002037) | 1.93447760 |
| 155 | Mediastinal lymphadenopathy (HP:0100721) | 1.93360290 |
| 156 | Abnormal gallbladder morphology (HP:0012437) | 1.91708703 |
| 157 | Hypoparathyroidism (HP:0000829) | 1.91158662 |
| 158 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.90811607 |
| 159 | Cellulitis (HP:0100658) | 1.88552348 |
| 160 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.87574700 |
| 161 | Meningitis (HP:0001287) | 1.86250998 |
| 162 | Hematochezia (HP:0002573) | 1.84972744 |
| 163 | Intellectual disability, mild (HP:0001256) | 1.82440946 |
| 164 | Sepsis (HP:0100806) | 1.81318155 |
| 165 | Hepatitis (HP:0012115) | 1.80682286 |
| 166 | Esophageal varix (HP:0002040) | 1.78003566 |
| 167 | Gangrene (HP:0100758) | 1.77959584 |
| 168 | Seborrheic dermatitis (HP:0001051) | 1.77091480 |
| 169 | Potter facies (HP:0002009) | 1.76750426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.54179272 |
| 2 | DYRK3 | 4.67018039 |
| 3 | DYRK1B | 4.41291816 |
| 4 | BMPR2 | 3.80559109 |
| 5 | RIPK1 | 3.79683813 |
| 6 | MAP4K1 | 2.89046375 |
| 7 | GRK7 | 2.83032641 |
| 8 | ERBB3 | 2.82641030 |
| 9 | EPHA3 | 2.68985564 |
| 10 | IRAK4 | 2.68587855 |
| 11 | PRPF4B | 2.42403747 |
| 12 | MST1R | 2.38503799 |
| 13 | NME1 | 2.03414762 |
| 14 | EPHB1 | 1.88287870 |
| 15 | NTRK1 | 1.82953996 |
| 16 | IKBKE | 1.76966221 |
| 17 | FGFR4 | 1.74640901 |
| 18 | ERN1 | 1.72827667 |
| 19 | BCR | 1.69835793 |
| 20 | CSK | 1.68262821 |
| 21 | SYK | 1.65741711 |
| 22 | ACVR1B | 1.65100838 |
| 23 | NLK | 1.54076211 |
| 24 | PINK1 | 1.48588723 |
| 25 | TYK2 | 1.48322525 |
| 26 | DYRK1A | 1.44921809 |
| 27 | ZAP70 | 1.44773403 |
| 28 | JAK3 | 1.44225922 |
| 29 | CDC42BPA | 1.41640901 |
| 30 | NME2 | 1.40808819 |
| 31 | DAPK2 | 1.40599665 |
| 32 | TXK | 1.38948591 |
| 33 | ADRBK2 | 1.38216224 |
| 34 | IKBKB | 1.34404740 |
| 35 | PRKCQ | 1.29186210 |
| 36 | CHUK | 1.28126827 |
| 37 | MST4 | 1.27790884 |
| 38 | PTK6 | 1.26843537 |
| 39 | MAP3K11 | 1.25522330 |
| 40 | FGR | 1.24355634 |
| 41 | MAP3K1 | 1.17534684 |
| 42 | TAOK1 | 1.15701113 |
| 43 | IRAK1 | 1.12389861 |
| 44 | CDK3 | 1.12205773 |
| 45 | MAPK15 | 1.11627318 |
| 46 | FRK | 1.05768148 |
| 47 | TNK2 | 1.05468736 |
| 48 | TAOK2 | 1.02908500 |
| 49 | ITK | 1.02824214 |
| 50 | TBK1 | 1.02512081 |
| 51 | LYN | 0.99832763 |
| 52 | RIPK4 | 0.97882307 |
| 53 | JAK2 | 0.95180026 |
| 54 | PLK2 | 0.94712572 |
| 55 | SIK3 | 0.94702864 |
| 56 | BTK | 0.94076053 |
| 57 | HIPK2 | 0.94034585 |
| 58 | TGFBR2 | 0.93972585 |
| 59 | TNIK | 0.93738618 |
| 60 | MKNK1 | 0.92397734 |
| 61 | EPHA2 | 0.91583164 |
| 62 | NEK9 | 0.90919519 |
| 63 | TRIB3 | 0.90761487 |
| 64 | EPHB2 | 0.90760860 |
| 65 | GRK5 | 0.88947630 |
| 66 | SMG1 | 0.88514868 |
| 67 | MAP3K6 | 0.87989796 |
| 68 | PRKG2 | 0.85292368 |
| 69 | EPHA4 | 0.83322807 |
| 70 | FGFR3 | 0.82928284 |
| 71 | PRKCD | 0.82303932 |
| 72 | PTK2 | 0.80684031 |
| 73 | MYLK | 0.80366552 |
| 74 | LCK | 0.79109110 |
| 75 | TESK2 | 0.79043906 |
| 76 | PRKCI | 0.78695526 |
| 77 | IRAK3 | 0.78395337 |
| 78 | PRKAA2 | 0.77199049 |
| 79 | LRRK2 | 0.76546781 |
| 80 | RAF1 | 0.75913781 |
| 81 | CSF1R | 0.75434817 |
| 82 | FER | 0.75330191 |
| 83 | SCYL2 | 0.69977131 |
| 84 | TYRO3 | 0.66758808 |
| 85 | PKN1 | 0.65876021 |
| 86 | HCK | 0.65767081 |
| 87 | PRKCE | 0.64275496 |
| 88 | MUSK | 0.64177850 |
| 89 | NTRK3 | 0.63550364 |
| 90 | BMPR1B | 0.62336899 |
| 91 | TESK1 | 0.61945387 |
| 92 | MAP3K12 | 0.61500843 |
| 93 | MAP3K10 | 0.61084933 |
| 94 | JAK1 | 0.60793367 |
| 95 | MKNK2 | 0.60647515 |
| 96 | DMPK | 0.58368845 |
| 97 | STK10 | 0.58341282 |
| 98 | SIK1 | 0.57332447 |
| 99 | PAK6 | 0.55269781 |
| 100 | EIF2AK2 | 0.55258001 |
| 101 | MATK | 0.54499935 |
| 102 | MAP3K3 | 0.54207317 |
| 103 | PDGFRA | 0.50823801 |
| 104 | PDPK1 | 0.50789552 |
| 105 | TEC | 0.50270571 |
| 106 | CLK1 | 0.50198433 |
| 107 | PIK3CG | 0.49858258 |
| 108 | CASK | 0.48734949 |
| 109 | CDK8 | 0.47556546 |
| 110 | TGFBR1 | 0.47237956 |
| 111 | MAP3K13 | 0.47043705 |
| 112 | MAP2K7 | 0.46212081 |
| 113 | MAPKAPK5 | 0.45967066 |
| 114 | MAP3K7 | 0.45585904 |
| 115 | CAMK1 | 0.45152494 |
| 116 | MAP3K4 | 0.44183372 |
| 117 | TIE1 | 0.44020744 |
| 118 | NTRK2 | 0.43410690 |
| 119 | BMX | 0.43214559 |
| 120 | MAPK7 | 0.41653001 |
| 121 | MAP2K2 | 0.40230968 |
| 122 | PIM2 | 0.39647948 |
| 123 | SRC | 0.39569298 |
| 124 | CAMK2G | 0.39441557 |
| 125 | AKT3 | 0.38706892 |
| 126 | PDK1 | 0.38671318 |
| 127 | ROCK2 | 0.38428877 |
| 128 | FYN | 0.38208584 |
| 129 | GRK6 | 0.37839700 |
| 130 | CDK6 | 0.36582715 |
| 131 | DDR2 | 0.36032684 |
| 132 | DAPK3 | 0.35614594 |
| 133 | MAPKAPK2 | 0.35149884 |
| 134 | ERBB4 | 0.35067528 |
| 135 | SIK2 | 0.34849746 |
| 136 | PAK3 | 0.34723040 |
| 137 | TSSK6 | 0.33517514 |
| 138 | KDR | 0.33511397 |
| 139 | MAPK11 | 0.32864886 |
| 140 | CAMKK2 | 0.32749332 |
| 141 | ARAF | 0.32737372 |
| 142 | BLK | 0.32644341 |
| 143 | KIT | 0.32174618 |
| 144 | MET | 0.31568925 |
| 145 | MELK | 0.31021693 |
| 146 | FES | 0.30044618 |
| 147 | PRKACA | 0.30036116 |
| 148 | PIM1 | 0.29532751 |
| 149 | STK24 | 0.28881010 |
| 150 | EGFR | 0.28818726 |
| 151 | KSR1 | 0.28724738 |
| 152 | PRKD2 | 0.27359904 |
| 153 | MAPK4 | 0.26770188 |
| 154 | CDK19 | 0.26018005 |
| 155 | INSR | 0.24936139 |
| 156 | MOS | 0.24733732 |
| 157 | MAPK3 | 0.23612892 |
| 158 | RPS6KA2 | 0.23027839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.61377020 |
| 2 | Histidine metabolism_Homo sapiens_hsa00340 | 4.58376175 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.40266541 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.73092521 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.67319918 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.27904895 |
| 7 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.84518976 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.64724505 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.28372160 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.27886626 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.18862993 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12329252 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.07959487 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.99666913 |
| 15 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.88972099 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.86961519 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.80959554 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.62483414 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47105731 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46386358 |
| 21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.41543756 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.38791993 |
| 23 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.35036952 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.30403488 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.28497381 |
| 26 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.27056747 |
| 27 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26303067 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.24709132 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23105120 |
| 30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.22621649 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.21795455 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.19137189 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19129330 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.16400943 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.14017503 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12693432 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.12513120 |
| 38 | Nicotine addiction_Homo sapiens_hsa05033 | 1.09874304 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.09504049 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.09274117 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.09127921 |
| 42 | Mineral absorption_Homo sapiens_hsa04978 | 1.03610222 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 1.03262468 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.02875417 |
| 45 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.02615987 |
| 46 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.02057086 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 0.99350692 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96348940 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94192444 |
| 50 | Salivary secretion_Homo sapiens_hsa04970 | 0.89781845 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89680276 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 0.89009330 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83023147 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80305442 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75325974 |
| 56 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75076679 |
| 57 | Melanoma_Homo sapiens_hsa05218 | 0.74135754 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73101050 |
| 59 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.72275733 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71266447 |
| 61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.70557922 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69343518 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68508775 |
| 64 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.67865573 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.67507778 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66992230 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66928765 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 0.66819258 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.63631520 |
| 70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63451252 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61539734 |
| 72 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.59931293 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.59417911 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58549392 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.58483445 |
| 76 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57621068 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57600617 |
| 78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57113190 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.56922693 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.56542362 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56146535 |
| 82 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54954411 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54692375 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54417901 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53556939 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52176394 |
| 87 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50113930 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50048464 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49880978 |
| 90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48802575 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48739084 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.48709712 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47302867 |
| 94 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46108675 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45775156 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45232309 |
| 97 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44935757 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44431242 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44394738 |
| 100 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44157855 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44017682 |
| 102 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43776823 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42830132 |
| 104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41559635 |
| 105 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41331200 |
| 106 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39651435 |
| 107 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.39614797 |
| 108 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.39550830 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.38477793 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38095274 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37976911 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37483039 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37459758 |
| 114 | Morphine addiction_Homo sapiens_hsa05032 | 0.37320697 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.36741884 |
| 116 | Taste transduction_Homo sapiens_hsa04742 | 0.36731199 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35983250 |
| 118 | Pertussis_Homo sapiens_hsa05133 | 0.34134638 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33468971 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.32906775 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32782826 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32708791 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32186786 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32036384 |
| 125 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31777682 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31585476 |
| 127 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28635790 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.28466931 |
| 129 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.28126192 |
| 130 | Legionellosis_Homo sapiens_hsa05134 | 0.27468740 |
| 131 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.27162676 |
| 132 | Bladder cancer_Homo sapiens_hsa05219 | 0.27091005 |
| 133 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.26545501 |
| 134 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.26269959 |
| 135 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.26161381 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.25492247 |
| 137 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25103784 |
| 138 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25075071 |
| 139 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.24930600 |
| 140 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.23738659 |
| 141 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.22380032 |
| 142 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21478971 |
| 143 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.19649158 |
| 144 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18006070 |
| 145 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.17752173 |
| 146 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.17014616 |
| 147 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.16544286 |
| 148 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.13896642 |
| 149 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.12072477 |
| 150 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.10779933 |

